Literature DB >> 10706097

A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities.

L C Li1, R M Chui, M Sasaki, K Nakajima, G Perinchery, H C Au, D Nojima, P Carroll, R Dahiya.   

Abstract

E-cadherin plays a critical role in many aspects of cell adhesion, epithelial development, and the establishment and maintenance of epithelial polarity. The loss of the adhesive function of E-cadherin is a critical step in the promotion of epithelial cells to a more malignant phenotype. We identified a C/A single nucleotide polymorphism at -160 from the transcriptional start site of the E-cadherin gene promoter. Transient transfection experiments showed that the A allele of this polymorphism decreased the transcriptional efficiency by 68% compared with the C allele (P<0.001). Electrophoretic mobility shift and footprinting assays revealed that the C allele had a stronger transcriptional factor binding strength than the A allele. These results indicate that the -160 C/A polymorphism has a direct effect on E-cadherin gene transcriptional regulation. This allelic variation may be a potential genetic marker that can help identify those individuals at higher risk for invasive/metastatic diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706097

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease.

Authors:  Heather Elding; Winston Lau; Dallas M Swallow; Nikolas Maniatis
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

2.  Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer.

Authors:  Yu-Jun Li; Xiang-Rui Ji
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  CDH1 promoter polymorphism (-347G-->GA) is a possible prognostic factor in sporadic colorectal cancer.

Authors:  Xiao-Ping Zou; Wei-Jie Dai; Jun Cao
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

4.  Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis.

Authors:  Ming Yin; Zhibin Hu; Dongfeng Tan; Jaffer A Ajani; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

5.  E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.

Authors:  Alicia Beeghly-Fadiel; Wei Lu; Yu-Tang Gao; Jirong Long; Sandra L Deming; Qiuyin Cai; Ying Zheng; Xiao-ou Shu; Wei Zheng
Journal:  Breast Cancer Res Treat       Date:  2009-10-16       Impact factor: 4.872

6.  Genetic screening for familial gastric cancer.

Authors:  Carla Oliveira; Gianpaolo Suriano; Paulo Ferreira; Paulo Canedo; Pardeep Kaurah; Rita Mateus; Ana Ferreira; António C Ferreira; Maria José Oliveira; Céu Figueiredo; Fátima Carneiro; Gisela Keller; David Huntsman; José Carlos Machado; Raquel Seruca
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

7.  The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Li-Xin Qiu; Ru-Tian Li; Jian-Bing Zhang; Wen-Zhao Zhong; Jian-Ling Bai; Bao-Rui Liu; Ming-Hua Zheng; Xiao-Ping Qian
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

8.  Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma.

Authors:  Christopher Ricketts; Maurice P Zeegers; Jan Lubinski; Eamonn R Maher
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

9.  Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo.

Authors:  W Jiao; K Miyazaki; Y Kitajima
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

10.  Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.

Authors:  Hidetaka Yamada; Kazuya Shinmura; Masanori Goto; Moriya Iwaizumi; Hiroyuki Konno; Hideki Kataoka; Masami Yamada; Takachika Ozawa; Toshihiro Tsuneyoshi; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Mol Cancer       Date:  2009-08-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.